3834
Y. Ferrand et al. / Tetrahedron: Asymmetry 16 (2005) 3829–3836
These cyclopropanes can be used as direct precursors of
several melatonin agonists.35
5.2.2. (ꢀ)-10-Vinyl-1,2,3,4,5,6,7,8-octahydro-1,4:5,8-di-
methanoanthracene-9-carboxaldehyde (ꢀ)-3. To solu-
tion of pure bromoaldehyde (+)-2 (1.58 mmol) in dry
toluene (15 mL) was added a solution of tributylvinyltin
(2 mmol) followed by Pd(Ph3P)2Cl2 (0.079 mmol) at
room temperature. The resulting mixture was heated
at 60 °C for 12 h. The reaction was monitored by TLC
and when the starting material had completely reacted,
the mixture was allowed to cool to room temperature.
The solvent was removed and the crude product was
purified by column chromatography (pentane/CH2Cl2
9/1). A white waxy solid was thus obtained in 90% yield.
½aꢂD ¼ ꢀ44 (c 0.50, CH2Cl2). H NMR d 10.46 (s, 1H);
6.92 (dd, 1H); 5.64 (m, 2H); 4.20 (m, 2H); 3.65 (m, 2H);
2.00 (m, 4H); 1.75 (m, 2H); 1.57 (m, 2H); 1.20 (m, 4H).
13C NMR d 192.2, 148.4, 144.5, 133.7, 130.4, 122.1,
120.4, 49.3, 41.7, 41.5, 26.9, 26.6. Mass EI
(m/z): calculated for C19H20O (M+Å): 264.1514, found:
264.1507.
4. Conclusion
In summary, the heterogeneous asymmetric cyclopropa-
nation of styrene catalyzed by new chiral ruthenium
porphyrin polymers occurs in a highly stereoselective
manner. Additionally, application to the synthesis of
cyanocyclopropane unknown in optically active form
was successful. Investigation of the catalytic properties
of these chiral ruthenium polymers for the epoxidation
of olefins is currently underway in our laboratory and
will be reported in due course.
20
1
5. Experimental
5.1. General experiments
5.2.3. 5,10,15,20-Tetrakis-[(1S,4R,5R,8S)-10-vinyl-1,2,
3,4,5,6,7,8-octahydro-1,4:5,8-dimethanoanthracene-9-yl]-
porphyrin 4. In a round bottom flask, a solution of
(ꢀ)-3 (0.75 mmol) in CHCl3 (60 mL) was mixed with
freshly distilled pyrrole (0.75 mmol). Argon was bubbled
through the solution for 5 min and BF3ÆEt2O
(0.22 mmol) was then added. The reaction mixture, pro-
tected from light, was stirred for 16 h at room temper-
ature, then p-chloranil (0.56 mmol) was added. The
solution was heated under reflux for 1 h and then
allowed to cool to room temperature. The solution was
concentrated and purified by column chromatography
(pentane/CH2Cl2 8/2) to give porphyrin 4 (26%). 1H
NMR d 8.80 (s, 8H); 7.26 (dd, 4H); 5.77 (m, 8H); 3.94
(m, 8H); 2.83 (m, 8H); 2.10–1.85 (m, 16H); 1.55–1.20
(m, 32H). UV–vis (CH2Cl2): kmax/nm (loge): 425 (5.75);
517 (4.41); 554 (4.22); 592 (4.14); 649 (4.19). Mass
(ESI, CH2Cl2/MeOH 9/1) (m/z): calculated for
C92H87N4[M+H]+: 1247.6930, found:1247.6921.
All reactions were performed under argon and were mag-
netically stirred. Solvents were distilled from appropriate
drying agent prior to use: Et2O and THF from sodium
and benzophenone, toluene from sodium, CH2Cl2 from
CaH2, CHCl3 from P2O5 and all other solvents were
HPLC grade. Commercially available reagents were used
without further purification unless otherwise stated. All
reactions were monitored by TLC with Merck pre-
coated aluminium foil sheets (Silica gel 60 with fluores-
cent indicator UV254). Compounds were visualized with
UV light at 254 and 365 nm. Column chromatographies
were carried out using silica gel from Merck (0.063–
0.200 mm). 1H NMR and 13C NMR in CDCl3 were
recorded using Bruker (Advance 500dpx and 300dpx
spectrometers) at 500 and 75 MHz, respectively. High-
resolution mass spectra were recorded on a ZabSpec
TOF Micromass spectrometer in ESI positif mode at
the CRMPO. Liquid UV–visible spectra were recorded
on a UVIKON XL from Biotech. All catalytic reactions
were controlled on a Varian CP-3380 Gas Chromato-
graph equipped with a CP-Chirasil-Dex Column.
5.2.4. Carbonyl[5,10,15,20-tetrakis-[(1S,4R,5R,8S)-10-
vinyl-1,2,3,4,5,6,7,8-octahydro-1,4:5,8-dimethanoanthra-
cene-9-yl]-porphyrinato] ruthenium (II) 5. A mixture of
the free base porphyrin 4 (48 lmol) and Ru3CO12
(144 lmol) in refluxing o-dichlorobenzene was let to
react for 2 h. The solvent was removed under high vac-
uum, and the crude product was purified by column
chromatography (pentane/CH2Cl2 8/2) to obtain the
pure metalloporphyrin 5 (43 lmol 90%). 1H NMR d
8.62 (AB system (5 Hz), 8H); 7.26 (dd, 4H); 5.73 (m,
8H); 3.91 (m, 8H); 2.95 (m, 4H); 2.64 (m, 4H); 2.15–
1.90 (m, 16H); 1.55–1.20 (m, 32H); UV–vis (CH2Cl2):
kmax/nm (loge): 416 (5.45), 531 (4.47). Mass (ESI,
CH2Cl2/MeOH 9/1) (m/z): calculated for C93H84ON4Ru
[M+H]+: 1397.5586, found: 1397.5663; IR (KBr):
5.2. Preparation of ruthenium porphyrin monomer
5.2.1. (+)-10-Bromo-1,2,3,4,5,6,7,8-octahydro-1,4:5,8-di-
methanoanthracene-9-carboxaldehyde (+)-2.10 To iron
powder (4.2 mmol) was added Br2 (12.6 mmol) to form
the corresponding Lewis acid, after 30 min, pure alde-
hyde (+)1 (4.2 mmol) in CCl4 (20 mL) was added. After
24 h at room temperature, the mixture was extracted
with 10% aqueous NaOH and water. Then, the com-
bined aqueous portions were extracted with CH2Cl2
three times. The combined organic portions were dried
and evaporated to give a brown solid. The crude prod-
uct was purified by column chromatography (pentane/
CH2Cl2 9/1) to give the pure bromoaldehyde (+)-2
m
CO = 1943.9 cmꢀ1
.
20
1
(80%). ½aꢂD ¼ þ44 (c 0.48, CH2Cl2). H NMR d 10.44
(s, 1H); 4.26 (m, 2H); 3.61 (m, 2H); 2.06–1.89 (m, 4H);
1.80 (m, 2H); 1.57 (m, 2H); 1.25–1.10 (m, 4H). 13C
NMR d 190.6, 149.0, 146.2, 128.6, 126.8, 48.5, 43.6,
42.3, 26.3, 25.7. Mass EI (m/z): calculated for
C17H17OBr (M+Å): 316.0462, found: 316.0460.
5.3. Preparation of polymers
In an oven dried hemolysis tube, metalloporphyrin 5
(7.2 lmol) was dissolved in the porogen (toluene
1.5 mmol). Then, styrene (277 lmol) and divinylbenzene
(or EGDMA) (340 lmol) were added to the solution.